more_reports

Streetwise Articles



Drone Co. Sees Record Revenue Jump
Source: Streetwise Reports  (11/8/22)
Volatus Aerospace Corp. has announced record third-quarter revenue, a 238% increase YOY. More >


The Tipping Point
Source: Dr. Jim Jones  (11/8/22)
Expert Dr. Jim Jones shares his extensive research on Emerita Resources Corp. to tell you why he believes this is only the tipping point for the company and what catalysts he sees up and coming. More >


Pharma Co. Signs Global License Deal for Eye Drops
Source: Streetwise Reports  (11/8/22)
Shares of Ocuphire Pharma Inc. traded 20% higher after the ophthalmology-focused biopharmaceutical firm reported it executed a global license agreement with FamyGen Life Sciences Inc. to develop and commercialize its Nyxol® Eye Drops for use in treating mydriasis, presbyopia, and night vision disturbances. More >


Michael Ballanger

A Most-Beguiling Fork
Source: Michael Ballanger  (11/7/22)
Expert Michael Ballanger believes markets are at a critical juncture, commonly referred to as a "fork in the road." In light of this, he reviews current Fed updates and movements in the gold and silver sectors to tell you where he believes the market is heading. More >


Expert Says Precious Metals Sector 'Looks Set To Soar Imminently'
Source: Clive Maund  (11/7/22)
Expert Clive Maund takes a look at some movements in the precious metals sector with a focus on the gold market to tell you where he believes it is headed. More >


Pan American and Agnico Team Up for Yamana
Source: Adrian Day  (11/7/22)
Expert Adrian Day believes the gold sector is picking up again and reviews two companies attempting to outbid Gold Fields in its proposed takeover of Yamana Gold.
More >


With 14 Active Rigs, Co. Lines Up Another Deposit To Drill
Source: Adam Schatzker  (11/4/22)
Given the amount of drilling happening at this Spanish project and the new drill data so far, it is likely the new resource estimate will exceed the historical one, noted a Research Capital Corp. report. More >


Organ Transplant Co.'s Q3 Revenues Rise 378%
Source: Streetwise Reports  (11/4/22)
Shares of medical technology firm TransMedics Group Inc. traded 24% higher to a new 52-week high after the company reported Q3/22 financial results highlighting a 378% YoY increase in net revenue and raised its FY/22 revenue estimates to US$80-85 million. More >


Telemedicine Co. Surges on Revenue News
Source: Streetwise Reports  (11/4/22)
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar. More >


Ron Struthers

The Fed Has Lots of Room To Move Rates Higher
Source: Ron Struthers  (11/4/22)
The Fed's mandate is 2% inflation and maximum employment. Expert Ron Struthers believes they have lots of room to soften the job market. Struthers also sees promise with three stocks. Gilat Satellite is growing sales, Callon Petroleum is undervalued, and Zonte Metals has a unique situation. More >


San Diego Co. Signs US$4.2B Deal To Develop mRNA Vaccines
Source: Streetwise Reports  (11/3/22)
Arcturus Therapeutics Holdings Inc. shares traded 19% higher yesterday after the firm reported it entered a global partnership with CSL Seqirus to develop and commercialize self-amplifying mRNA vaccines worldwide. More >


Analyst Sees 'Opportunity' in Golden Triangle Project
Source: Streetwise Reports  (11/3/22)
A Haywood Securities analyst initiates coverage on Dolly Varden Silver Corp., saying "now is the right time" for investing in the company. More >


Solar Co.'s Equipment Sales Rise 74% YOY
Source: Streetwise Reports  (11/3/22)
Shares of turnkey residential solar firm Sunrun Inc. traded 19% higher after the company reported Q3/22 financial results that included a 44% YoY increase in revenue and a 21% gain in its installed customer base. More >


Analyst Says, 'Invest Now' in this Attractive Mining Co.
Source: Geordie Mark  (11/2/22)
This firm, with both high-grade silver and gold assets in one project, already has a resource large enough for a mining-processing operation, noted a Haywood Securities report. More >


Junior on Cutting Edge of Lithium Extraction Industry
Source: Streetwise Reports  (11/2/22)
Rover Metals Corp., which is pivoting to critical metals and minerals, is looking to a peer’s feasibility study to help prove the viability of the resource at its new project. More >


Pharma Co. Earns Big Rewards from Global License Deal
Source: Streetwise Reports  (11/2/22)
Kiniksa Pharmaceuticals Ltd. shares traded 12% higher yesterday after the company reported Q3/22 financial results that included a 720% YoY increase in net revenue attributed to a combination of organic growth and increases in global licensing revenue. More >


Michael Ballanger

The 'Bear Killer' Does it Again
Source: Michael Ballanger  (11/1/22)
Expert Michael Ballanger reviews recent updates in the stock market to tell you where he believes it is headed and why he thinks October was "The Bear Killer," with countless bear markets ending and bull markets possibly beginning today, November 1, 2022. More >


PFS on Rare Earth Co.'s B.C. Project Expected to be 'Robust'
Source: Mark Reichman  (11/1/22)
With this season's drilling behind it, the Canadian explorer plans to start, by year-end, the next step in advancing its project, noted a Noble Capital Markets report. More >


Biopharma Co. Trades 39% Higher
Source: Streetwise Reports  (11/1/22)
Actinium Pharmaceuticals Inc. shares traded 39% higher yesterday to a new 52-week high after the firm reported topline data from its Phase 3 SIERRA study of Iomab-B in patients with active relapsed or refractory acute myeloid leukemia. During the pivotal trial, Iomab-B met its primary pre-established endpoint of durable complete remission or dCR of six months post-initial remission following a bone marrow transplant. More >


Ron Struthers

Gold Is At/Near a Bottom, Let's Make Over 5% Yield With Newmont While We Wait
Source: Ron Struthers   (11/1/22)
The decline in gold prices will not last forever, and we just witnessed a double bottom and now heard Central Banks are buying at a record pace. Newmont mining is expert Ron Struthers' go-to stock when gold prices start to move, and he believes it currently offers great value with an over 5% dividend yield. More >


Newly Found Feeder Zone at Gold Project to Benefit Mine Plan
Source: Mike Niehuser  (11/1/22)
The high-grade and mineable widths of this zone will likely improve the economics of the future mining operation in Fiji, noted a ROTH Capital Partners report. More >


Michael Ballanger

Expert Michael Ballanger's Top Picks
Source: Michael Ballanger  (10/31/22)
Expert Michael Ballanger reviews updates from some major junior mining companies, such as Getchell Gold Corp. and Norseman Silver, among others, to tell you his opinion on each company and where junior mining is heading as a sector. More >


Biopharma Gains Two Cancer Cell Therapy Programs and a Target Price 10 Times Current
  (10/31/22)
This developer of cancer immunotherapies will take possession of these clinical-stage assets in a transaction with GSK and subsequently advance them toward approval, noted a ROTH Capital Partners report. More >


Adrian Day

Nestle Continues To Execute as Profits Grow
Source: Adrian Day  (10/31/22)
Today expert Adrian Day discusses results from two core holdings, both doing well, according to him, despite cost inflation. Day believes you can use current weakness to accumulate a portfolio of blue chips.
More >


Precious Metals Sector Believed To Be Close to Major Uptrend
Source: Clive Maund  (10/31/22)
With the possibility of a Fed pivot looming, expert Clive Maund touches on his views of the precious metals sector and why he believes you should invest in it sooner rather than later. More >


Showing Results: 3801 to 3825 of 25193 Prev Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts